NISA INVESTMENT ADVISORS, LLC - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 202 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$6,396
+67.6%
3450.0%0.00%
Q2 2023$3,816
+76220.0%
345
-6.0%
0.00%
Q1 2023$50.0%3670.0%0.00%
Q4 2022$5
-99.9%
367
+6.4%
0.00%
Q3 2022$5,0000.0%3450.0%0.00%
Q2 2022$5,000
-16.7%
3450.0%0.00%
Q1 2022$6,0000.0%3450.0%0.00%
Q4 2021$6,000
-90.0%
345
-91.5%
0.00%
Q3 2021$60,000
-25.9%
4,0450.0%0.00%
-100.0%
Q2 2021$81,000
+912.5%
4,045
+1072.5%
0.00%
Q1 2021$8,000
-11.1%
3450.0%0.00%
Q4 2020$9,000
-82.0%
345
-71.1%
0.00%
Q3 2020$50,000
+455.6%
1,195
+512.8%
0.00%
Q2 2020$9,000
-18.2%
195
+8.3%
0.00%
Q1 2020$11,000
-70.3%
180
-40.0%
0.00%
Q4 2019$37,000
+428.6%
300
+200.0%
0.00%
Q3 2019$7,000
-12.5%
1000.0%0.00%
Q2 2019$8,000
-27.3%
1000.0%0.00%
Q1 2019$11,000
+10.0%
1000.0%0.00%
Q4 2018$10,000
-23.1%
1000.0%0.00%
Q3 2018$13,0001000.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q2 2020
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 640,688$14,787,0002.73%
DeepCurrents Investment Group LLC 416,800$9,620,0000.33%
DUALITY ADVISERS, LP 105,668$2,439,0000.21%
EULAV Asset Management 335,000$7,732,0000.21%
Virtus ETF Advisers LLC 19,375$447,0000.19%
Hennion & Walsh Asset Management, Inc. 135,214$3,121,0000.19%
PDT Partners, LLC 110,592$2,552,0000.18%
KETTLE HILL CAPITAL MANAGEMENT, LLC 70,256$1,622,0000.16%
ALTRINSIC GLOBAL ADVISORS LLC 168,800$3,896,0000.12%
WOODWARD DIVERSIFIED CAPITAL, LLC 8,939$206,0000.12%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders